Breslow R - Search Results

1

Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug.

Marks PA, Breslow R. Marks PA, et al. Among authors: breslow r. Nat Biotechnol. 2007 Jan;25(1):84-90. doi: 10.1038/nbt1272. Nat Biotechnol. 2007. PMID: 17211407 Review.

2

Creation of a histone deacetylase 6 inhibitor and its biological effects [corrected].

Lee JH, Yao Y, Mahendran A, Ngo L, Venta-Perez G, Choy ML, Breslow R, Marks PA. Lee JH, et al. Among authors: breslow r. Proc Natl Acad Sci U S A. 2015 Sep 29;112(39):12005-10. doi: 10.1073/pnas.1515882112. Epub 2015 Sep 14. Proc Natl Acad Sci U S A. 2015. PMID: 26371309 Free PMC article.

3

Development of a histone deacetylase 6 inhibitor and its biological effects.

Lee JH, Mahendran A, Yao Y, Ngo L, Venta-Perez G, Choy ML, Kim N, Ham WS, Breslow R, Marks PA. Lee JH, et al. Among authors: breslow r. Proc Natl Acad Sci U S A. 2013 Sep 24;110(39):15704-9. doi: 10.1073/pnas.1313893110. Epub 2013 Sep 10. Proc Natl Acad Sci U S A. 2013. PMID: 24023063 Free PMC article.

4

A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

Richon VM, Emiliani S, Verdin E, Webb Y, Breslow R, Rifkind RA, Marks PA. Richon VM, et al. Among authors: breslow r. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3003-7. doi: 10.1073/pnas.95.6.3003. Proc Natl Acad Sci U S A. 1998. PMID: 9501205 Free PMC article.

5

Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

Richon VM, Webb Y, Merger R, Sheppard T, Jursic B, Ngo L, Civoli F, Breslow R, Rifkind RA, Marks PA. Richon VM, et al. Among authors: breslow r. Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5705-8. doi: 10.1073/pnas.93.12.5705. Proc Natl Acad Sci U S A. 1996. PMID: 8650156 Free PMC article.

6

Polar/apolar chemical inducers of differentiation of transformed cells: strategies to improve therapeutic potential.

Marks PA, Breslow R, Rifkind RA, Ngo L, Singh R. Marks PA, et al. Among authors: breslow r. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6358-62. doi: 10.1073/pnas.86.16.6358. Proc Natl Acad Sci U S A. 1989. PMID: 2762329 Free PMC article.

7

Inhibitors of histone deacetylase are potentially effective anticancer agents.

Marks PA, Rifkind RA, Richon VM, Breslow R. Marks PA, et al. Among authors: breslow r. Clin Cancer Res. 2001 Apr;7(4):759-60. Clin Cancer Res. 2001. PMID: 11309319 No abstract available.

8

Histone deacetylase inhibitors as new cancer drugs.

Marks PA, Richon VM, Breslow R, Rifkind RA. Marks PA, et al. Among authors: breslow r. Curr Opin Oncol. 2001 Nov;13(6):477-83. doi: 10.1097/00001622-200111000-00010. Curr Opin Oncol. 2001. PMID: 11673688 Review.

9

Histone deacetylases and cancer: causes and therapies.

Marks P, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK. Marks P, et al. Among authors: breslow r. Nat Rev Cancer. 2001 Dec;1(3):194-202. doi: 10.1038/35106079. Nat Rev Cancer. 2001. PMID: 11902574 Review.

10

Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors.

Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA, Breslow R, Pavletich NP. Finnin MS, et al. Among authors: breslow r. Nature. 1999 Sep 9;401(6749):188-93. doi: 10.1038/43710. Nature. 1999. PMID: 10490031

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results